FDA announces more recalls of antacids containing potential cancer-causing chemical

Generic pills (Getty, Shidlovski)
Published:
Updated:

INDIANAPOLIS (WTHR) — The Food and Drug Administration has recalled several lots of heartburn medications.

The recall, which includes a generic version of Zantac, were found to have trace amounts of a substance that may be linked to cancer.

The substance known as N-Nitrosodimethylamine (NDMA) has been labeled by the World Health Organization as a "probable human carcinogen."

Denton Pharma Inc. and Appco Pharma recalled several batches of unexpired ranitidine tablets due to the possible presence of NDMA.

On Wednesday, Mylan added to the list of recalled lots.

Recalled batches include nizatidine capsules sold in bottles of 60 with an expiration date of May, as well as nizatidine capsules sold in bottles of 30 with an expiration date of January.

No injuries associated with these medications has been reported.

Consumers with questions can call 1-888-INFO-FDA or contact their health care provider.

Filed under: